Skip to main content
Year archive

Innate Pharma — 2016 filings

All 74 regulatory filings released by Innate Pharma (IPH) in 2016, sourced directly from the official regulator.

74 Filings
2016 Period
2016 filings (74)
Filing Released Lang
IPH annonce des évolutions dans son management et sa gouvernance
Board/Management Information
2016-12-19 French
IPH announces key leadership and corporate governance change
Board/Management Information
2016-12-19 English
Données cliniques pour lirilumab et IPH4102 à l'ASH2016
AGM Information
2016-12-05 French
Further clinical data for lirilumab and IPH4102 presented at ASH 2016
Investor Presentation
2016-12-05 English
PR in English
Regulatory Filings
2016-11-30 English
CP en français
Regulatory Filings
2016-11-30 French
SITC 2016 : Présentation de données cliniques
Legal Proceedings Report
2016-11-12 French
SITC 2016 : Clinical Data Release
Investor Presentation
2016-11-12 English
InnInvestor conference call on November 14, 2016
Report Publication Announcement
2016-11-10 English
Conférence téléphonique investisseur le 14 nov. 2016
Report Publication Announcement
2016-11-10 French
PRELIMINARY PHASE 1/2 EFFICACY DATA SITC 2016
Regulatory Filings
2016-11-08 English
DONNÉES PRÉLIMINAIRES SITC 2016
Report Publication Announcement
2016-11-08 French
CP en français
Interim / Quarterly Report 9M 2016
2016-11-03 French
PR in English
Earnings Release 9M 2016
2016-11-03 English
CP en français
Earnings Release FY 2016
2016-10-26 French
PR in English
Regulatory Filings
2016-10-26 English
PR in English
Regulatory Filings
2016-10-13 English
CP en français
Regulatory Filings
2016-10-13 French
PR in English
Regulatory Filings
2016-10-13 English
CP en français
Regulatory Filings
2016-10-13 French
Safety Data for Lirilumab in Combination with Nivolumab or Ipilimumab
Legal Proceedings Report
2016-10-09 English
Données de tolérance pour lirilumab en combinaison ESMO 2016
Earnings Release FY 2016
2016-10-09 French
PR in English
Regulatory Filings
2016-09-29 English
CP en français
Regulatory Filings
2016-09-29 French
CP en français
Regulatory Filings
2016-09-28 French
PR in English
Regulatory Filings
2016-09-28 English
Innate Pharma : Half-year financial report June 30, 2016
Interim / Quarterly Report H2 2016
2016-09-08 English
Innate Pharma : Rapport financier semestriel au 30 juin 2016
Interim / Quarterly Report H2 2016
2016-09-08 French
CP IPH résultats financiers pour le premier semestre 2016
Interim / Quarterly Report H1 2016
2016-09-08 French
PR IPH financial results for the first half of 2016
Interim / Quarterly Report H1 2016
2016-09-08 English
European analyst and investor event in London on July 13
Report Publication Announcement
2016-07-04 English
Présentation pour les analystes et investisseurs européens le 13/07
Report Publication Announcement
2016-07-04 French
ASCO 2016 : Presentation du protocole de l'essai clinique de Phase I
Investor Presentation
2016-06-05 French
asco 2016: Phase I study protocol investigating IPH4102 in CTCL
Regulatory Filings
2016-06-05 English
PR in English
Share Issue/Capital Change
2016-06-03 English
CP en français
AGM Information
2016-06-03 French
PR in English
AGM Information
2016-06-03 English
CP en français
Share Issue/Capital Change
2016-06-03 French
Report and termination of the liquidity contract with Gilbert Dupont
Regulatory Filings
2016-05-18 English
Bilan de fin du contrat de liquidité conclu avec Gilbert Dupont
Regulatory Filings
2016-05-18 French
Présentation aux investisseurs et analystes du 16 mai 2016 à New-York
Investor Presentation
2016-05-16 French
Investor & Analyst Update, New York, May 16th, 2016
Investor Presentation
2016-05-16 English
PR in English
Interim / Quarterly Report Q1 2016
2016-05-04 English
CP en français
Earnings Release Q1 2016
2016-05-04 French
PR in English
Investor Presentation
2016-04-28 English
CP en français
Report Publication Announcement
2016-04-28 French
PR in English
AGM Information
2016-04-27 English
CP en français
AGM Information
2016-04-27 French
Document de référence 2015
Annual Report FY 2015
2016-04-26 French
IPH AACR 2016 IPH52
Regulatory Filings
2016-04-19 English
IPH AACR 2016 IPH52
Investor Presentation
2016-04-19 French
IPH AACR 2016 CD73
Earnings Release FY 2016
2016-04-18 English
IPH AACR 2016 CD73
Regulatory Filings
2016-04-18 French
IPH AACR 2016 monalizumab
Earnings Release FY 2016
2016-04-18 French
IPH AACR 2016 monalizumab
Regulatory Filings
2016-04-18 English
CP en français
Investor Presentation
2016-03-17 French
PR in English
Regulatory Filings
2016-03-17 English
FY results 2015
Earnings Release FY 2015
2016-02-18 English
Résultats annuels 2015
Earnings Release FY 2015
2016-02-18 French
Start of Phase I trial of monalizumab in combination with durvalumab
Investor Presentation
2016-02-08 English
Démarrage de l'essai de Phase I monalizumab avec durvalumab
Regulatory Filings
2016-02-08 French
Number of shares and voting rights of Innate Pharma as at Feb 3, 2016
Share Issue/Capital Change
2016-02-05 English
Nombre d'actions et droits de vote d'Innate Pharma au 03/02/16
Share Issue/Capital Change
2016-02-05 French
Sanofi et Innate Pharma collaborent ...
Capital/Financing Update
2016-01-11 French
Innate Pharma in-licenses OREGA biotech's anti-CD39 program
Regulatory Filings
2016-01-10 English
Innate Pharma acquiert le programme d'anticorps inhibiteurs de CD39
Capital/Financing Update
2016-01-10 French
Number of shares and voting rights as at January 6, 2016
Share Issue/Capital Change
2016-01-09 English
Nombre d’actions et de droits de vote au 6 janvier 2016
Share Issue/Capital Change
2016-01-09 French
Bilan annuel du contrat de liquidité
Report Publication Announcement
2016-01-08 French
FULL-YEAR REPORT ON INNATE PHARMA'S LIQUIDITY CONTRACT
Net Asset Value
2016-01-08 English
Financial calendar for 2016
Report Publication Announcement
2016-01-07 English
Calendrier financier pour 2016
Report Publication Announcement
2016-01-07 French
Upcoming investor conferences
Report Publication Announcement
2016-01-05 English
Prochains rendez-vous investisseurs
Report Publication Announcement
2016-01-05 French